Revision of Oncopeptides (Sweden)

{{DISPLAYTITLE:Oncopeptides (Sweden)}}
Portola Pharmaceuticals is an American clinical stage biotechnology company that researches, develops, and commercializes drugs. The company focuses primarily on drugs used in the treatment of thrombosis and hematological malignancies.Founded and headquartered in South San Francisco, California, Portola Pharmaceuticals is a member of the NASDAQ Biotechnology Index.<small> from [https://en.wikipedia.org/wiki/Portola_Pharmaceuticals Wikipedia]</small>

{{SF|
{{Twt|oncopeptides}}
{{Wb|https://oncopeptides.se/|oncopeptides.se}}
{{Wb|https://oncopeptides-us.com/en/|oncopeptides-us.comen/}}
}}
{{IDF|
{{Wd|Q30269225}}
{{Gog|/g/11c6w2tp79}}
}}

{{VHID|60201486230}}{{#subtitle: <big>company in Stockholm, Sweden</big>}}